March 13, 2018

Wildflower Health Receives $8 Million Capital Investment in Funding Round Led by Health Enterprise Partners

Mobile Health Leader Poised for Continued Organizational Growth and Significant  Expansion of Family Health Platform

March 07, 2018 — SAN FRANCISCO (PRWEB) — Wildflower Health today announced it has secured $8 million in capital investment to advance its mission of growing healthy families. The funding round was led by Health Enterprise Partners, a growth equity firm specializing in healthcare services and information technology whose investors include some of the largest health systems and health plans across the country. Existing investors Hatteras Venture Partners and Echo Health also participated. As part of the round, Ezra Mehlman of HEP joins the Wildflower Health Board of Directors.

Wildflower Health is a leading mobile health software company that connects families to health resources on their smartphone. Wildflower Health empowers the “Chief Health Officer of the Home” with tools that promote healthy pregnancies, track family health and support the growth of each family member based on their individual health needs over time. The company leverages its unique engagement model to improve access to care, impact short and long-term consumer decisions, and drive clinical outcomes.

“We have built a flexible platform that is highly engaging and bridges critical gaps between individuals and the healthcare they need,” said Leah Sparks, founder and CEO of Wildflower Health. “We believe in the power of connection, and we believe we have developed a unique approach to creating greater connectivity in healthcare. This latest round of investment will allow us to advance our capabilities, extend our impact and sustain our overall growth.”

Proceeds from the round will enable Wildflower to deepen investment in product development, strengthen its core team and build on its recent successes. Within the past year, Wildflower has tripled its recurring license revenue and expanded its user base by more than 10x. The company also successfully launched its Family Health platform, which enables individuals to manage pregnancy and family health from an integrated application.

“We are extremely impressed with the momentum Wildflower has generated within the digital health space,” said Mehlman. “This company has a proven approach and a significant base of clients. It is quickly becoming a major force in redefining how organizations use mobile technologies to engage with, and improve the health of, the individuals they support. We are excited to see what Leah and team can accomplish moving forward.”

About Health Enterprise Partners

Health Enterprise Partners invests primarily in privately held, middle market companies in health care services and health care information technology. Central to HEP’s strategy is its unique and extensive hospital system and health plan network, 26 members of which are investors in HEP’s funds. HEP seeks to invest in companies that improve the quality of the patient experience, expand access, and reduce the cost of health care. For more information, please visit

About Wildflower Health

Wildflower Health produces mobile health programs that help families better connect to healthcare and help healthcare enterprises influence behaviors across a lifetime of health decisions. The company’s mobile applications target women and their families to drive prevention, risk identification and connections to care right on the smartphone, starting in pregnancy and extending as family health needs evolve. Wildflower Health’s software is highly configurable for health enterprise clients to reflect their health services and benefits, creating a highly personalized experience for application users. The company’s solutions are offered to consumers worldwide by leading health plans, hospitals and employers. For more information, visit

About Hatteras Venture Partners

Hatteras Venture Partners is a venture capital firm based in Durham, NC with a focus on seed and early stage healthcare investing. The firm focuses on biopharmaceutical, healthcare IT, medical device, and diagnostic opportunities. Hatteras has approximately $450 million under management in five venture capital funds. The firm is led by a seasoned team of entrepreneurs and operators and has a long and successful track record of seed and early stage investing and company formation. To learn more about Hatteras Venture Partners, please visit